Insulin Delivery Using Microneedles in Type 1 Diabetes

Completed · Phase 2/Phase 3

Conditions studied: Type 1 Diabetes Mellitus

In brief

The goal of this study is to determine if microneedles can effectively and painlessly deliver insulin to children and young adults with type 1 diabetes.

Key facts

Study ID

NCT00837512

Run by

Emory University

People needed

16

Starts

2008-09-01

Expected to finish

2013-07-01

Last updated by the study team

2014-01-08

Who can join

Age: 8 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥ 8 years of age
• <19 years of age
• Type 1 Diabetes for at least 2 years
• Uses a conventional, FDA-approved insulin pump for the past year
• Uses Lispro insulin
• Mean hemoglobin A1C ≤ 8.5 % for the past year
• Body mass index ≤ 85th percentile for age
• Understand and be willing to adhere to the study protocol

You may not qualify if…

• Type 2 Diabetes
• Acanthosis nigricans
• Clinically significant major organ system disease
• On glucocorticoid therapy
• Insulin requirement ≥ 150 U/day
• Illness on the day of the study
• Cognitive impairment (IQ < 85 or > 2 grades behind age-appropriate grade)
• Pregnant or breast-feeding (if female).

Where it is running

• Emory University — Atlanta, Georgia, United States
• Emory University — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.